Our previous work demonstrates that blocking the stress-signaling system using R121919, an antagonist to the type-1 corticotropin-releasing factor receptor (CRFR1) can prevent cognitive impairment, synaptic/dendritic loss, and Aβ plaque accumulation in AD transgenic (Tg) mice [15]. Here, CRHR1 is linked to Cognitive impairment.